Heartland Research Associates, LLC
1709 S Rock Rd
Wichita, Kansas 67207
316-689-6629 http://www.heartlandresearch.com kstoddard@heartlandresearch.com

Use our guide to learn which trials are right for you!

HRA believes that the progress made in research today will give us hope and assurance of a tomorrow. HRA originally began as a department of Family Medicine East, the owners developed this highly successful department into its own LLC in 1991. Located within the heartland of the U.S., HRA is now a dedicated, independent clinical research site, specializing in providing Phase I inpatient and outpatient through phase V clinical research services for pharmaceutical, nutritional and medical device industries. HRA's main site is located in east Wichita, Kansas, with 3 satellite sites in west Wichita, Arkansas City, Newton and Augusta, Kansas. HRA's mission is to provide quality medical care to their research participants, with a commitment to accurate and precise data for their sponsors. The resulting strong relationship with their patients aids in successful recruitment, compliance, and retention.

HRA has conducted more than 875 national and multinational clinical trials in the therapeutic areas of: Dermatology, Device, Endocrinology, Gastroenterology, Genotyping, Infectious Disease, Male Health & Erectile Dysfunction, Musculoskeletal & Connective Tissue Disorders, Neurology, Ophthalmology, Otolaryngology, Pain Management, Pediatrics, Pulmonology/Critical Care, Respiratory, Urology/Nephrology, Vascular/Cardiovascular Disorders, Weight Loss and Women's Health.

Some of the sponsors and CRO Heartland has worked with include: 3M, Abbott, Acer/Excel, Advanced Biologics, Agouron, Alcon, Almirall Prodesfarma, Astra Merck Astra Zeneca, Aventis, BARR, Bayer, Bio Cryst, Boehringer Ingelheim, BMS, Cellegy, Centocor, Chiesi, ClinTrials, CIBA, Covance, DepoMed, Eisai, Eli Lilly, Endo Pharm., Genaissance, Genentech, Genomics, Glaxo Wellcome, GSK, Hisamitsu, HumaScan, i3 Research, ICON, Insight Vision, Janssen, Kendle, KOS, KV Pharm., MDS Pharma, Merck, McNeil, Novo Nordisk, Novartis, Omnicare, Organon, OrthoMcNeil, Otsuka, Paragon, Parke-Davis, Pfizer, Pharmacia, Phoenix, Praecis, Proctor & Gamble, Purdue, Quintiles, Regeneron, Reliant, Resource Solutions, Roche, Ross/Abbott, RWJ, Sandoz, Sankyo, Schering Plough, Searle, Sepracor, SKB, Sucampo, Takeda, TAP, Target, VELA, ViroPharma, Winston Labs, WyethAyerst.

Terry L. Poling, MD, DABFP, FAAFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Poling is an AMA delegate for Kansas, acts as Chairman and Medical Director for the Wichita Preferred Provider Association, and is a Past-President for the Kansas Medical Society. Additionally, Dr. Poling is a Clinical Assistant Professor at the University of Kansas School of Medicine.

Dr. Terry D. Klein, MD, DABFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Klein is a Clinical Assistant Professor at the University of Kansas School of Medicine. Additionally, Dr. Klein is a President of an IPA, and is a Past President for the Kansas Medical Society and currently holds a board position.

Dr. Thomas Klein MD, DABFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Klein is a Clinical Assistant Professor at the University of Kansas School of Medicine. Additionally, Dr. Klein is certified for full privileges in EGD's, fiber optic sigmoidoscopy and colonoscopy.

Dr. Scott L. Meyers, MD, DABFP, CCPI is board-certified in Family Practice. Dr. Meyers has served as MSSC delegate to the Kansas Medical Society and is currently serving a position on the insurance committee for the County Medical Society. Additionally, Dr. Meyers serves as a Clinical Instructor at the University of Kansas School of Medicine.

Dr. Tracy R. Klein, MD, DABFP, CCPI is board-certified in Family Practice. Dr. Klein is CDE eligible, and is actively involved with an affiliated organization, Heartland Diabetes Associates, LLC.

HRA's Medical Management has an average of over 9 years in Research. HRA also has over 30 board-certified affiliated physicians.

The staff at HRA has over 100 years of cumulative research experience. HRA currently staffs 18 full-time Clinical Research Coordinators - many being CCRC's. There are 10 Research Assistants, 7 Patient Referral Specialists, 2 Regulatory Specialists, 2 Receptionists, 4 Quality Assurance staff, a Source Writer as well as a Financial Specialist, all of whom work diligently to provide care for both patients and sponsors. HRA also has 3 Trained Alzheimer's Rating Specialists, 2 Smoking Cessation Counselors and a contract Registered Dietician. HRA has implemented a Quality Assurance Department in 2007 to ensure the quality and accuracy of its research.


Advertising is done through the television, newspaper, direct mail, website and radio medias. Patients are also drawn from an internal extensive database of over 85,000 patients. Community physicians and study participants have also referred many patients. HRA also has access to affiliated physician databases. This all contributes to HRA's enrollment success of >114%, with a low screen failure rate and high enrollment, with a patient population ranging from pediatrics to geriatrics. Heartland Diabetes Association, LLC, aides in HRA's ability to recruit patients by providing access to more than 1000 active diabetic patients and by employing a knowledgeable diabetic staff, including a Certified Diabetic Educator. The Medical Management Directors are Recognized Providers by ADA and NCQA - the only family practice physicians in Kansas to hold this distinction.


Cardiology/Vascular Diseases
Dental/Maxillofacial Surgery
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Ophthalmology
Otolaryngology
Pediatrics/Neonatology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology

HRA's main office is located in the same facility as Family Medicine East, but is a distinctly separate entity and maintains over 3,400 square feet of the 16, 580 square foot building, additionally HRA owns the 2,912 square foot building next door. HRA has, or has access to: Radiology, Densitometry, Uroflow Machine, Sahar extremity densitometry, refrigerated centrifuge, EKG machines, EGD, sigmoid and colonoscopy services, -20° and -70° freezers, ambulatory blood pressure monitoring, registered dietician, CLIA/OSHA Certified Lab & Phlebotomy, Spirometry, Pollen Counting, Colposcopy L.E.E.P, Certified Smoking Cessation Counselors and a Pulse Oximetry. The main office also has 6 dedicated exam rooms, while each of the satellite offices has a minimum of 1 dedicated exam room. Each office has a general storage facility, dedicated monitor room/s with high speed cable internet connections, locked study drug closet or cabinet and conference rooms for site/ initiation visits. Each facility is also HIPPA compliant and there are IATA/FAA certified staff for the shipment of hazardous materials.

Each office is located near hotels and easy driving distance from the airport with easy highway accessibility. There are many attractions, museums and fine dining restaurants in the area for those spending extra time in at any of the offices.


Kathy Stoddard
Clinical Research Director
Heartland Research Associates, LLC
East Office
1709 S Rock Rd
Wichita, KS 67207
USA
316-689-6629
316-689-6690 (fax)
kstoddard@heartlandresearch.com
www.heartlandresearch.com


We've found
20 trials
at this facility
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Obsessive-Compulsive Disorder Clinical Trial
BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Pneumococcal Disease Clinical Trial
Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Anthrax Clinical Trial
VELOCITY: An Anthrax Vaccine Clinical Study
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Severe Osteoarthritis of the Knee Clinical Trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee
Status: Enrolling, Phase III
Updated: 12/19/2017
mi
from
Wichita, KS
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Efficacy of a Plant-derived Quadrivalent VLP Vaccine in the Elderly
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Pneumococcal Disease Clinical Trial
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Wichita, KS
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Clostridium Difficile Associated Disease Clinical Trial
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Pneumococcal Disease Clinical Trial
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Generalized Anxiety Disorder Clinical Trial
Randomized Trial of Adult Subjects With Generalized Anxiety Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Clostridium Difficile Vaccine Efficacy Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Obesity Clinical Trial
Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Non-Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials